Joseph Eid - 17 Feb 2026 Form 4 Insider Report for GERON CORP (GERN)

Reporting relationship: EVP, R&D; Chief Medical Office
Issuer ticker: GERN
Reported as of: 17 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 18:11:23 UTC
Prior SEC filing: 12 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Michelle Robertson, attorney-in-fact

Key filing fact

Joseph Eid filed Form 4 for GERON CORP (GERN) on 19 Feb 2026.

Key facts

This page summarizes Joseph Eid's Form 4 filing for GERON CORP (GERN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Feb 2026, 18:11.

Change

Previous filing in this sequence was filed on 12 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001780247 Primary reporting owner

Eid Joseph

Relationship: EVP, R&D; Chief Medical Office
Address: C/O GERON CORPORATION, 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY
Signature: /s/ Michelle Robertson, attorney-in-fact
Signature date: 19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GERN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +2,220,000
Change %
Price: $0.000000
Shares after: 2,220,000
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,220,000
Exercise price: $1.80
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests in 48 equal monthly installments commencing on March 17, 2026, provided that the Reporting Person provides continuous service to the Issuer on each such vesting date.